An underlying systemic disease is common among patients with chronic, treatment resistant urticaria, referred to a tertiary referral centre for autoimmune diseases.
G
G
Katsikas
Z T
ZT
Karageorgaki
G K
GK
Bertsias
E
E
Spanakis
H D
HD
Kritikos
P
P
Sidiropoulos
D T
DT
Boumpas
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D002908:Chronic Disease; D003240:Connective Tissue Diseases / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012189:Retrospective Studies; D012867:Skin / Q000473:pathology; D014581:Urticaria / Q000188:drug therapy / Q000209:etiology*; D014657:Vasculitis / Q000150:complications* / Q000453:epidemiology / Q000473:pathology; D055815:Young Adult
D005938:Glucocorticoids; D006633:Histamine Antagonists